Pharmacokinetics of Olmesartan Medoxomil plus Hydrochlorothiazide Combination in Healthy Subjects

Author： Kreutz Reinhold   Bolbrinker Juliane   Huber Matthias  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.26, Iss.1, 2006-01, pp. : 29-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antihypertensive efficacy of olmesartan medoxomil alone and in combination with hydrochlorothiazide

By Chrysant Steven G   Chrysant George S  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 657-667

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide

By Rump Lars Christian   Sellin Lorenz  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2231-2242

Informa Healthcare

Access to resources Recommend Favorite

Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension

By Deeks Emma D.  

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 209-220

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Olmesartan Following Oral Administration of its Prodrug, Olmesartan Medoxomil: In Healthy Volunteers and Hypertensive Patients

By Yoshihara Kazutaka  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1329-1342

Adis International

Access to resources Recommend Favorite

Olmesartan medoxomil/amlodipine/hydrochlorothiazide fixed-dose combination: a guide to its use in hypertension

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 11, 2011-11 ,pp. : 6-9

Adis International

Access to resources Recommend Favorite